UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
Genexine said its investigational DNA vaccine for cervical cancer has impro...
by Jeong Sae-im
|
2020-04-28 14:48
라인
Researchers start testing pancreatitis drug to fight Covid-19
The Ministry of Food and Drug Safety has approved a local investigator-init...
by Kim Yun-mi
|
2020-04-28 11:22
라인
Genexine to present test results at US cancer academy
Genexine will release the interim results of its clinical trials on the com...
by Shim Hyun-tai
|
2020-04-27 16:14
라인
‘Parasiticide showed antiviral effect as potential Covid-19 drug’
“Niclosamide showed an antiviral effect, regulating the autophagy function ...
by Jeong Sae-im
|
2020-04-24 12:27
라인
French envoy visits Pasteur Korea to watch Covid-19 research
French Ambassador Philippe Lefort visited Institut Pasteur Korea (IPK) in P...
by Jeong Sae-im
|
2020-04-23 17:13
라인
Multinational drugmakers donated ₩30 billion last year
Twenty-eight multinational pharmaceutical companies operating in Korea dona...
by Kim Yun-mi
|
2020-04-23 15:09
라인
4 drugs recorded two-digit sales growth in Q1 despite Covid-19
The new coronavirus slowed the growth of the overall outpatient drug prescr...
by Jeong Sae-im
|
2020-04-23 12:18
라인
Medytox’s faking data unpunishable due to expired statute of limitations
Prosecutors have reportedly found that Medytox fabricated data to win appro...
by Jeong Sae-im
|
2020-04-22 11:28
라인
Abclon derives clinical materials for CAR-T treatment of ovarian cancer
Antibody-based therapeutics developer Abclon said Tuesday that it has succe...
by Shim Hyun-tai
|
2020-04-21 17:49
라인
Multidisciplinary cure is mainstream cancer treatment but cumbersome
“Cancer” is the area where multidisciplinary treatments are being made most...
by Park Gi-taek
|
2020-04-21 17:09
라인
Whistleblowers, shareholders furious over Medytox’s rebuttal
The whistleblowers who revealed Medytox’s alleged illegal manufacturing of ...
by Jeong Sae-im
|
2020-04-21 15:19
라인
ImmuneMed confident of drug candidate’s effect on Covid-19
ImmuneMed said its inflammatory viral disease treatment HzVSF (humanized vi...
by Jeong Sae-im
|
2020-04-21 13:23
라인
Medytox files suit to cancel administrative order
Medytox has filed a lawsuit against the Ministry of Food and Drug Safety to...
by Shim Hyun-tai
|
2020-04-20 16:37
라인
DM Bio signs CDMO contract with Abion for antibody treatment
DM Bio said it has signed a CDMO (contract development and manufacturing or...
by Shim Hyun-tai
|
2020-04-17 16:03
라인
Medytox CEO charged with making, selling botulinum toxin illegally
Prosecutors said Friday they have indicted Medytox CEO Jung Hyun-ho on char...
by Jeong Sae-im
|
2020-04-17 16:00
라인
Researchers to test asthma drug to treat Covid-19
Local infectious disease specialists said they would evaluate the potential...
by Kim Yun-mi
|
2020-04-16 16:20
라인
Bukwang to test its antiviral drug against Covid-19
Bukwang Pharm said its hepatitis B treatment Levovir (ingredient: clevudine...
by Jeong Sae-im
|
2020-04-16 12:20
라인
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer ...
by Kim Yun-mi
|
2020-04-16 10:48
라인
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide
Institut Pasteur Korea, an institute specializing in infectious diseases, a...
by Shim Hyun-tai
|
2020-04-14 17:49
라인
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
Gilead Sciences’ last-minute modification of the clinical design of remdesi...
by Kim Yun-mi
|
2020-04-10 15:36
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top